DoveTree

DoveTree is an innovative biopharmaceutical company focused on developing first-in-class drug pipelines for serious and chronic diseases in the fields of autoimmune disorders and cancer. The company was founded by biopharmaceutical entrepreneur Gregory Verdine, who currently serves as the CEO. Verdine is an internationally renowned entrepreneur, scientist, and senior investor in the biopharmaceutical field, having participated in the establishment of more than ten biopharmaceutical companies, including five listed companies. DoveTree is actively exploring the "Artificial Intelligence (AI) + Robotics" sector in new drug research and development.